CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment

BACKGROUND: Lung cancer is the leading cause of cancer-related mortality globally. Discovering effective biomarkers for early diagnosis and prognosis is important to reduce the mortality rate and ensure efficient therapy for lung cancer patients. C-type lectin domain family 3 member B (CLEC3B) has b...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Cell Int
Glavni autori: Sun, Jiaxing, Xie, Tian, Jamal, Muhammad, Tu, Zhenbo, Li, Xinran, Wu, Yingjie, Li, Jingyuan, Zhang, Qiuping, Huang, Xiaoxing
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Primary Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7110733/
https://ncbi.nlm.nih.gov/pubmed/32265595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01183-1
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items